Skip to main content

Cystocele

0
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

PFM Medical
PFM MedicalCA - Carlsbad
2 programs
TiLOOP® PRO Plus AN/A1 trial
surgical mesh implantationN/A1 trial
Active Trials
NCT02690220Completed54Est. Jul 2017
NCT01084889Completed292Est. Jun 2016
City Therapeutics
City TherapeuticsMA - Cambridge
1 program
rug weaving-like plication techniqueN/A1 trial
Active Trials
NCT07336108CompletedEst. Dec 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
City Therapeuticsrug weaving-like plication technique
PFM MedicalTiLOOP® PRO Plus A
PFM Medicalsurgical mesh implantation

Clinical Trials (3)

Total enrollment: 346 patients across 3 trials

NCT07336108City Therapeuticsrug weaving-like plication technique

RUG-WEAVING PLICATION IN CYSTOCELE TREATMENT

Start: Dec 2025Est. completion: Dec 2025
N/ACompleted
NCT02690220PFM MedicalTiLOOP® PRO Plus A

Anterior Pelvic Prolapse Reconstruction With TiLOOP® PRO A Polypropylene Mesh

Start: Feb 2016Est. completion: Jul 201754 patients
N/ACompleted
NCT01084889PFM Medicalsurgical mesh implantation

Anterior Pelvic Prolapse Reconstruction With TiLOOP® Total 6

Start: Apr 2010Est. completion: Jun 2016292 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.